May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Combined photodynamic therapy (PDT) with posterior subtenon triamcinolone acetonide for CNV in Non–AMD patients – 1–year results.
Author Affiliations & Notes
  • E.G. Lucena
    Retina, Visoclinic, Rio de Janeiro, Brazil
    Retina,
    Clinica de Olhos do Rio, Rio de Janeiro, Brazil
  • M.D. Rachid
    Cornea,
    Clinica de Olhos do Rio, Rio de Janeiro, Brazil
  • M.L. Aiube
    Retina, Visoclinic, Rio de Janeiro, Brazil
  • A.S. Lucena
    Retina, Visoclinic, Rio de Janeiro, Brazil
  • J.E. Goncalves
    Retina, Oftalmoclinica Botafogo, Rio de Janeiro, Brazil
    Ophthalmology, Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil
  • Footnotes
    Commercial Relationships  E.G. Lucena, Novartis R; M.D. Rachid, None; M.L. Aiube, None; A.S. Lucena, None; J.E. Goncalves, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3152. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E.G. Lucena, M.D. Rachid, M.L. Aiube, A.S. Lucena, J.E. Goncalves; Combined photodynamic therapy (PDT) with posterior subtenon triamcinolone acetonide for CNV in Non–AMD patients – 1–year results. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3152.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We report the long term (1–year) visual acuity and fluorescein angiographic effects of a single photodynamic therapy treatment combined with posterior subtenon triamcinolone acetonide (TA) injection in non–AMD patients with choroidal neovascular membranes in a pilot study. Methods: This non–randomized prospective clinical interventional study included 5 eyes of 5 patients having classic non–AMD subfoveal choroidal neovascular membranes. Standardized visual acuity, anterior segment biomicroscopy, IOP measure, fundus examination and fluorescein angiography were recorded at baseline and during follow up (12 months). Five days after treatment with photodynamic therapy using verteporfin (6 mg/m2) in a standard fashion, all patients received a 40 mg posterior subtenon injection of triamcinolone acetonide with 24GA Jelco. Results: The mean visual acuity improved 2 lines (range 3 to 0 lines) from baseline to the follow up at week 52. No leakage in the primary lesion was noticed in 3 eyes at week 52. Secondary elevation of the IOP was observed in 4 patients until 5 weeks after the TA injection and anti–glaucoma medications were prescribed. No major complications were observed. Conclusions: These preliminary data of 1–year follow up suggest this combined approach for treatment of choroidal neovascular membranes may have a remarkable benefit in the Non AMD group of patients providing a long term improvement of visual acuity after a single photodynamic therapy treatment with posterior subtenon triamcinolone.

Keywords: choroid: neovascularization • photodynamic therapy • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×